Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FERMT1 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
mRNA | PIWIL4 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | C1QC | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
mRNA | KCNN4 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | EPS8L3 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-07 |
mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-06 |
mRNA | RAB23 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | MYO1F | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | ATP1A1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |